Abiopharma

News list

Schacterle Amy 🔴 sold 1.1K shares of Acumen Pharmaceuticals, Inc. (ABOS) at $1.98 Transaction Date: Jan 07, 2026 | Filing ID: 001633

Full text

News bot Jan. 9, 2026, 9:41 p.m.
🔍 Schacterle Amy (Executive)

Company: Acumen Pharmaceuticals, Inc. (ABOS)

Report Date: 2026-01-07
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 1,097
Detailed Transactions and Holdings:
- Sold 1,097 shares of Common Stock at $1.9838 per share (Direct)
  Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 7,703.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2025.
- F2: The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $1.9550 to $2.0100. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.